U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 214900

BREXAFEMME (IBREXAFUNGERP CITRATE)
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: IBREXAFUNGERP CITRATE
Proprietary Name: BREXAFEMME
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N214900
Product Number: 001
Approval Date: Jun 1, 2021
Applicant Holder Full Name: SCYNEXIS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top